# Phio Pharmaceuticals Corp. (PHIO)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/PHIO/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -8.14M | $ -8.04M | $ 0 | $ 12.60M |
| 2025 | $ 0 | $ -8.91M | $ -8.18M | $ 0 | $ 20.15M |
| 2024 | $ 0 | $ -7.52M | $ -7.48M | $ 0 | $ 4.72M |
| 2023 | $ 0 | $ -11.71M | $ -11.63M | $ 35.0K | $ 7.73M |
| 2022 | $ 0 | $ -12.82M | $ -13.68M | $ 170.0K | $ 10.84M |
| 2021 | $ 0 | $ -15.79M | $ -14.16M | $ 295.0K | $ 21.93M |
| 2020 | $ 0 | $ -11.20M | $ -11.24M | $ 642.0K | $ 13.02M |
| 2019 | $ 27.1K | $ -11.50M | $ -11.25M | $ 518.0K | $ 5.75M |
| 2018 | $ 182.3K | $ -9.72M | $ -9.94M | $ 0 | $ 13.58M |
| 2017 | $ 20.2K | $ -16.77M | $ -13.09M | $ 0 | $ 1.83M |
| 2016 | $ 26.1K | $ -12.37M | $ -10.68M | $ 0 | $ 10.86M |
| 2015 | $ 47.7K | $ -14.35M | $ -10.35M | $ 0 | $ 8.89M |
| 2014 | $ 100.3K | $ -12.43M | $ -11.10M | N/A | $ 2.75M |
| 2013 | $ 567.5K | $ -29.76M | $ -9.09M | N/A | $ 4.94M |
| 2012 | $ 140.0K | $ -18.60M | $ -7.33M | N/A | $ -5.84M |
| 2011 | $ 0 | $ -15.01M | $ -14.76M | $ 534.0K | $ -587.0K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.14 |
| Current Ratio | 15.87 |

## Other views

- [Metrics](https://sponda.capital/en/PHIO.md)
- [Charts](https://sponda.capital/en/PHIO/charts.md)
- [Compare](https://sponda.capital/en/PHIO/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.